• Epilepsy
  • Multiple Sclerosis
  • Movement Disorders
  • Dementia and Alzheimer Disease
  • Neuromuscular
  • Stroke
  • Headache and Migraine
  • Sleep Disorders

Latest News

Post-Hoc Analysis of ADAPT Reveals Several Subgroup Responders to Efgartigimod
Post-Hoc Analysis of ADAPT Reveals Several Subgroup Responders to Efgartigimod

March 21st 2023

Efgartigimod-treated patients consistently outperformed placebo regardless of concomitant medication, thymectomy status, and timing of diagnosis.

Post-Hoc Analysis of CHAMPION MG Study Highlights Ravulizumab’s Effects on Specific Muscle Domains
Post-Hoc Analysis of CHAMPION MG Study Highlights Ravulizumab’s Effects on Specific Muscle Domains

March 21st 2023

FDA Potentially Mulling Neurofilament Light as Critical Biomarker in Upcoming AdComm Meeting of Tofersen
FDA Potentially Mulling Neurofilament Light as Critical Biomarker in Upcoming AdComm Meeting of Tofersen

March 20th 2023

Supplementing N-163 Beta Glucan Shows Disease-Modifying Effects as Adjuvant in Duchenne Muscular Dystrophy
Supplementing N-163 Beta Glucan Shows Disease-Modifying Effects as Adjuvant in Duchenne Muscular Dystrophy

March 20th 2023

Minor Differences in Inclusion Criteria, Baseline Characteristics Impact Motor and Nonmotor Clinical Outcomes in Presymptomatic Spinal Muscular Atrophy
Minor Differences in Inclusion Criteria, Baseline Characteristics Impact Motor and Nonmotor Clinical Outcomes in Presymptomatic Spinal Muscular Atrophy

March 20th 2023

Mind Moments podcast
NeuroVoices
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Gold Standard Centers
Brain Games
ACTRIMS 2022
Medical World News

Conference Coverage

View All
Raised Awareness and Need For Improvements to End of Life Care in Neuromuscular Disorders: Ambereen Mehta, MD, MPH
Raised Awareness and Need For Improvements to End of Life Care in Neuromuscular Disorders: Ambereen Mehta, MD, MPH

March 21st 2023

The Use of Molecular Testing in Limb Girdle Muscular Dystrophy: Douglas Sproule, MD, MSc
The Use of Molecular Testing in Limb Girdle Muscular Dystrophy: Douglas Sproule, MD, MSc

March 21st 2023

Post-Hoc Analysis of ADAPT Reveals Several Subgroup Responders to Efgartigimod
Post-Hoc Analysis of ADAPT Reveals Several Subgroup Responders to Efgartigimod

March 21st 2023

Post-Hoc Analysis of CHAMPION MG Study Highlights Ravulizumab’s Effects on Specific Muscle Domains
Post-Hoc Analysis of CHAMPION MG Study Highlights Ravulizumab’s Effects on Specific Muscle Domains

March 21st 2023

Video Series
Video Interviews
Podcasts

Most Recent

© 2023 MJH Life Sciences

All rights reserved.